DOXIL - 59676-960-02 - (doxorubicin hydrochloride)

Alphabetical Index


Drug Information of DOXIL

Product NDC: 59676-960
Proprietary Name: DOXIL
Non Proprietary Name: doxorubicin hydrochloride
Active Ingredient(s): 2    mg/mL & nbsp;   doxorubicin hydrochloride
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, SUSPENSION, LIPOSOMAL
Coding System: National Drug Codes(NDC)

Labeler Information of DOXIL

Product NDC: 59676-960
Labeler Name: Janssen Products, LP
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA050718
Marketing Category: NDA
Start Marketing Date: 19951117

Package Information of DOXIL

Package NDC: 59676-960-02
Package Description: 1 VIAL, SINGLE-USE in 1 CARTON (59676-960-02) > 25 mL in 1 VIAL, SINGLE-USE

NDC Information of DOXIL

NDC Code 59676-960-02
Proprietary Name DOXIL
Package Description 1 VIAL, SINGLE-USE in 1 CARTON (59676-960-02) > 25 mL in 1 VIAL, SINGLE-USE
Product NDC 59676-960
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name doxorubicin hydrochloride
Dosage Form Name INJECTION, SUSPENSION, LIPOSOMAL
Route Name INTRAVENOUS
Start Marketing Date 19951117
Marketing Category Name NDA
Labeler Name Janssen Products, LP
Substance Name DOXORUBICIN HYDROCHLORIDE
Strength Number 2
Strength Unit mg/mL
Pharmaceutical Classes Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA]

Complete Information of DOXIL


General Information